Ryan D Nipp
Overview
Explore the profile of Ryan D Nipp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
2810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagalapuram V, Popuri N, Nipp R, Ulahannan S, Lau-Min K
JCO Oncol Pract
. 2025 Mar;
:OP2400872.
PMID: 40030085
Global incidence of hepatocellular carcinoma (HCC) is rising along with its mortality burden, and more than half of the patients require systemic therapy for advanced disease. There is an ongoing...
2.
Jiang C, Nipp R, Hong A, Shih Y, Xing J, Mullins M, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250008.
PMID: 40029662
No abstract available.
3.
Peppercorn J, Hasler J, Hu B, Tagai E, Zahner G, Lam A, et al.
Cancer
. 2025 Jan;
131(2):e35721.
PMID: 39813089
Background: Little is known about the role that charitable copay assistance (CPA) plays in addressing access to care and financial distress. The study sought to evaluate financial distress and experience...
4.
Peppercorn J, Gelin M, Masteralexis T, Zafar S, Nipp R
JCO Oncol Pract
. 2025 Jan;
21(1):5-11.
PMID: 39793546
Financial toxicity (FT) is now a well-recognized issue affecting many patients with cancer and their families. The field is rapidly moving from a focus on describing this problem to efforts...
5.
Shen Y, Hu X, Nipp R, Yabroff K, Hong A, Liao J, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2449038.
PMID: 39630452
No abstract available.
6.
Mather R, Mather R, Nipp R, Nipp R, Balanza G, Stone T, et al.
Anesthesiology
. 2024 Nov;
142(3):500-510.
PMID: 39601585
Background: With estimated global postoperative mortality rates at 1% to 4% leading to approximately 3 million to 12 million deaths per year, an urgent need exists for reliable measures of...
7.
Henderson N, Ortiz-Olguin E, Bourne G, Pywell C, Rose J, Williams G, et al.
J Natl Compr Canc Netw
. 2024 Nov;
22(9):602-609.
PMID: 39536438
Background: The incorporation of electronic patient-reported outcomes (ePROs), such as the Geriatric Assessment (GA) and treatment preferences, into decision-making for pancreatic cancer has been limited by clinician- and system-level barriers...
8.
Jiang C, Yabroff K, Nipp R, Han X, Hu X, Liao J, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2443978.
PMID: 39509134
No abstract available.
9.
Chen F, Nipp R, Han X, Zheng Z, Yabroff K, Jiang C
J Gen Intern Med
. 2024 Oct;
PMID: 39438376
No abstract available.
10.
Durbin S, Lundquist D, Pelletier A, Petrillo L, Bame V, Turbini V, et al.
Cancer
. 2024 Oct;
131(1):e35586.
PMID: 39387163
Background: Little is known about financial toxicity in early-phase clinical trial (EP-CT) participants. This study sought to describe financial toxicity in EP-CT participants and assess associations with patient characteristics and...